MyFinsight
Home
Blog
About
Contact
rnac: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$3,154K
Accounts receivable
$722K
Cash and cash
equivalents
$143,384K
Long-term prepaid
expenses and other assets
$5,551K
Investments
$2,000K
Long-term restricted cash
$1,735K
Goodwill
$48,163K
In-process research and
development assets
$150,600K
Right-of-use assets, net
$4,972K
Property and equipment,
net
$12,394K
Total current assets
$147,260K
Total assets
$372,675K
Accumulated other
comprehensive loss
-$4,587K
Accumulated deficit
-$729,797K
Total liabilities and
stockholders deficit
$372,675K
Total stockholders
deficit
-$35,844K
Additional paid-in capital
$698,537K
Common stock, 0.0001
par value...
$3K
Total liabilities
$408,519K
Deferred tax
liabilities, net
$16,141K
Contingent value right
liability, net of current...
$369,000K
Warrant liability
$848K
Lease liabilities,
net of current...
$8,727K
Total current
liabilities
$13,803K
Lease liabilities
$3,876K
Accrued expenses and
other current...
$7,702K
Accounts payable
$2,225K
Back
Back
Balance Sheet
source: myfinsight.com
Cartesian Therapeutics, Inc. (RNAC)
Cartesian Therapeutics, Inc. (RNAC)